ChemicalBook > Product Catalog >Analytical Chemistry >Standard >Pharmaceutical Impurity Reference Standards >Bosutinib Impurity 5

Bosutinib Impurity 5

Bosutinib Impurity 5 Suppliers list
Company Name: TargetMol Chemicals Inc.
Tel: +1-781-999-5354 +1-00000000000
Email: marketing@targetmol.com
Products Intro: Product Name:PF-06651481-00;PF0665148100;Bosutinib Isomer I;PF 06651481 00
CAS:1391063-17-4
Package:25 mg;5 mg Remarks:REAGENT;FOR LABORATORY USE ONLY
Company Name: China National Standard Pharmaceutical Corporation Limited
Tel: +8615391658522
Email: overseasales@yongstandards.com
Products Intro: Product Name:Bosutinib Impurity 5
CAS:1391063-17-4
Purity:0.95 Package:Vials
Company Name: BOC Sciences  
Tel: 16314854226
Email: info@bocsci.com
Products Intro: Product Name:Bosutinib Isomer
CAS:1391063-17-4
Purity:>95%
Company Name: Shanghai EFE Biological Technology Co., Ltd.  
Tel: 021-65675885 18964387627
Email: info@efebio.com
Products Intro: Product Name:Bosutinib Isomer 1, Free Base
CAS:1391063-17-4
Purity:98% Package:5mg;10mg;25mg
Company Name: Roark Standards  
Tel: 0755-83552066 15986688328
Email: service@roarkstandards.com
Products Intro: Product Name:Bosutinib Impurity 5
CAS:1391063-17-4
Purity:98% HPLC Package:10MG;25MG;50MG;100MG
Bosutinib Impurity 5 Basic information
Product Name:Bosutinib Impurity 5
Synonyms:Bosutinib isomer 1;3-Quinolinecarbonitrile, 4-[(3,5-dichloro-4-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methyl-1-piperazinyl)propoxy]-;Bosutinib Isomer I (PF-06651481-00);Bosutinib Isomer I
CAS:1391063-17-4
MF:C26H29Cl2N5O3
MW:530.45
EINECS:
Product Categories:
Mol File:1391063-17-4.mol
Bosutinib Impurity 5 Structure
Bosutinib Impurity 5 Chemical Properties
solubility Chloroform (Slightly), DMSO (Slightly), Methanol (Slightly, Heated)
form Solid
color White to Light Brown
Stability:Stable under recommended storage conditions., Stable Under Recommended Storage C
Safety Information
MSDS Information
Bosutinib Impurity 5 Usage And Synthesis
UsesKinase inhibitors, such as?bosutinib,?are useful cancer drugs but their target specificity is not fully understood. 4-[(3,5-Dichloro-4-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methyl-1-piperazinyl)propoxy]-3-quinolinecarbonitrile has been employed as a clinical kinase inhibitor bosutinib to elucidate the recognition mechanism between the ATP-binding site and the compound.
Bosutinib Impurity 5 Preparation Products And Raw materials
Tag:Bosutinib Impurity 5(1391063-17-4) Related Product Information
3,4-Dimethoxynitrobenzene Bosutinib Bosutinib N-oxide N,N'-Diisopropylcarbodiimide 3-Quinolinecarbonitrile,4-chloro-6-Methoxy-7-[3-(4-Methyl-1-piperazinyl)propoxy]- 3-ACETAMIDOPHENOL